DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2220926/ahead-of-bunge-global-bg-q4-earnings-get-ready-with-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220926 Feb 05, 2024 - Get a deeper insight into the potential performance of Bunge Global (BG) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. 0

https://www.zacks.com/stock/news/2220588/general-mills-gis-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2220588 Feb 02, 2024 - General Mills (GIS) closed the most recent trading day at $64.80, moving -0.05% from the previous trading session. 0

https://www.zacks.com/stock/news/2220553/deere-de-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2220553 Feb 02, 2024 - In the closing of the recent trading day, Deere (DE) stood at $392.60, denoting a -0.27% change from the preceding trading day. 0

https://www.zacks.com/stock/news/2220563/kroger-kr-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2220563 Feb 02, 2024 - The latest trading day saw Kroger (KR) settling at $46.14, representing a -1.22% change from its previous close. 0

https://www.zacks.com/stock/news/2220511/abbvie-abbv-q4-earnings-beat-raises-sales-view-for-key-drugs?cid=CS-ZC-FT-analyst_blog|earnings_article-2220511 Feb 02, 2024 - AbbVie???s (ABBV) fourth-quarter earnings and sales beat estimates. Management hikes the 2027 forecast for new immunology drugs to more than $27 billion. 0

https://www.zacks.com/stock/news/2220405/compared-to-estimates-exxon-xom-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2220405 Feb 02, 2024 - While the top- and bottom-line numbers for Exxon (XOM) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. 0

https://www.zacks.com/stock/news/2220387/cboe-cboe-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2220387 Feb 02, 2024 - The headline numbers for CBOE (CBOE) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. 0

https://www.zacks.com/stock/news/2220372/brookfield-renewable-bep-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2220372 Feb 02, 2024 - The headline numbers for Brookfield Renewable (BEP) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. 0

https://www.zacks.com/stock/news/2220373/wisdomtree-inc-wt-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2220373 Feb 02, 2024 - The headline numbers for WisdomTree, Inc. (WT) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. 0

https://www.zacks.com/stock/news/2220345/charter-chtr-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2220345 Feb 02, 2024 - The headline numbers for Charter (CHTR) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. 0